3
Announcements
Trials
Browse
Landscape
Phase
Phase 1/2
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Head & Neck
1
Conditions
Keratosis, Actinic
16
Carcinoma, Basal Cell
7
Liver Neoplasms
3
Carcinoma, Non-Small-Cell Lung
3
Squamous Cell Carcinoma of Head and Neck
2
Skin Neoplasms
2
Pancreatic Neoplasms
2
Neoplasm Metastasis
2
Mycosis Fungoides
2
Mesothelioma, Malignant
2
Leukoplakia, Oral
2
Colorectal Neoplasms
2
Cholangiocarcinoma
2
Basal Cell Nevus Syndrome
2
Barrett Esophagus
2
Warts
1
Thyroid Neoplasms
1
Thyroid Cancer, Papillary
1
Signs and Symptoms
1
Sezary Syndrome
1
Salivary Gland Neoplasms
1
Retinoblastoma
1
Precancerous Conditions
1
Pleural Diseases
1
Pituitary Neoplasms
1
Pain
1
Optic Nerve Glioma
1
Oligodendroglioma
1
Non-Muscle Invasive Bladder Neoplasms
1
Neuroectodermal Tumors, Primitive
1
Interventions
Radiotherapy
8
Cisplatin
8
Cetuximab
8
pembrolizumab
5
Fluorouracil
5
Drug Therapy
5
Surveys and Questionnaires
4
Celecoxib
4
Radiotherapy, Intensity-Modulated
3
Radiation
3
Sentinel Lymph Node Biopsy
2
Psychiatric Rehabilitation
2
Polymerase Chain Reaction
2
Physical Therapy Modalities
2
Nicotine
2
Interviews as Topic
2
Injections
2
Immunohistochemistry
2
High-Energy Shock Waves
2
Counseling
2
Chemoradiotherapy
2
Bupropion
2
Aminolevulinic Acid
2
trametinib
1
traY protein, E coli
1
toripalimab
1
sodium thiosulfate
1
sargramostim
1
motexafin gadolinium
1
mogamulizumab
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Completed
×
Mouth Neoplasms
×
Photochemotherapy
×
Clear all
NCT03638622
2021-02-21
UH3-India
Massachusetts General Hospital
Phase 1/2
Completed
30 enrolled
4 charts